EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Unmet Needs in Maintenance Therapy for Extensive Stage Small Cell Lung Cancer

Luis Paz-Ares, Brinda Gupta, Javier Baena, Stephen V Liu

Clinical Lung Cancer · 2025-05 · 26 (3) · 168-178

DOI: 10.1016/j.cllc.2025.02.015 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Lung Cancer, 2025-05. Verfasst von Luis Paz-Ares und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitario 12 de Octubre, H120H120-CNIO Lung Cancer Clinical Research Unit, Universidad Complutense & Ciberonc, Madrid, Spain. Hauptthemen laut MEDLINE: Small Cell Lung Carcinoma, Lung Neoplasms, Maintenance Chemotherapy, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: Jazz Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Small cell lung cancer (SCLC) is a highly aggressive malignancy and an exceptionally lethal disease; most patients present with extensive stage (ES) disease at diagnosis. Very little had changed in the treatment of ES-SCLC for decades until immune checkpoint inhibitor (ICI) therapy combined with chemotherapy followed by ICI maintenance monotherapy was added to standard treatment paradigms in 2019. Despite this important advance, high rates of relapse are still observed in patients with ES-SCLC and long-term survival rates remain low, with approximately 40% of patients proceeding to receive second-line treatment. There is an urgent need for novel treatment strategies to improve patient outcomes. In this review, we describe the rationale for maintenance therapy approaches in ES-SCLC and summarize the existing data on chemotherapy, ICIs, and other agents in the first-line maintenance setting. Predictive biomarkers, SCLC subtypes, and new therapeutics in development are discussed including lurbinectedin, antibody-drug conjugates, and T-cell engager molecules.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Small Cell Lung CarcinomaLung NeoplasmsMaintenance ChemotherapyImmune Checkpoint InhibitorsAntineoplastic Combined Chemotherapy ProtocolsHumansNeoplasm Staging

Stichwörter der Autor:innen

Antibody-drug conjugatesDNA topoisomerasesImmune checkpoint inhibitorsPARP inhibitorsT-cell engager molecules

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Hospital Universitario 12 de Octubre, H120H120-CNIO Lung Cancer Clinical Research Unit, Universidad Complutense & Ciberonc, Madrid, Spain.
  • Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC.
  • Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC. Electronic address: stephen.liu@gunet.georgetown.edu.

Förderung

  • Jazz Pharmaceuticals

Zitieren

APA

Paz-Ares, L., Gupta, B., Baena, J., & Liu, S. V. (2025). Unmet Needs in Maintenance Therapy for Extensive Stage Small Cell Lung Cancer. Clinical Lung Cancer, 26(3), 168-178. https://doi.org/10.1016/j.cllc.2025.02.015

Vancouver

Paz-Ares L, Gupta B, Baena J, Liu SV. Unmet Needs in Maintenance Therapy for Extensive Stage Small Cell Lung Cancer. Clinical Lung Cancer. 2025;26(3):168-178. doi:10.1016/j.cllc.2025.02.015

BibTeX
@article{PazAres2025,
  author = {Paz-Ares, Luis and Gupta, Brinda and Baena, Javier and Liu, Stephen V},
  title = {Unmet Needs in Maintenance Therapy for Extensive Stage Small Cell Lung Cancer},
  journal = {Clinical Lung Cancer},
  year = {2025},
  volume = {26},
  number = {3},
  pages = {168--178},
  doi = {10.1016/j.cllc.2025.02.015}
}
Kostenlos starten →